Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study-Reference-Cited by-同舟云学术

Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study

Published:2016-03-16 Issue:4 Volume:48 Page:224-234
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Mamza Jil¹,Mehta Rajnikant²,Donnelly Richard¹,Idris Iskandar¹

Affiliation:

1. Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham, Nottingham, UK;

2. Research Design Services (East Midlands), School of Medicine, University of Nottingham, Nottingham, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/07853890.2016.1157263

Reference31 articles.

1. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

2. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

3. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

4. National Institute for Health and Clinical Excellence. Type 2 diabetes: newer agents. 2009; http://www.nice.org.uk/guidance/CG87 [last accessed 19 July 2013].

5. Initial Choice of Oral Glucose-Lowering Medication for Diabetes Mellitus

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study;Drugs - Real World Outcomes;2023-05-09

2. A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2022-11-30

3. Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER study;Current Medical Research and Opinion;2022-11-28

4. Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study;Frontiers in Endocrinology;2022-10-31

5. Why We Need Sex-Gender Medicine: The Striking Example of Type 2 Diabetes;Diabetology;2022-08-11